Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up on Analyst Upgrade

Key Points

• Analyst upgrade drove the move: KeyCorp upgraded Lumexa Imaging to “strong buy,” sending shares from a $9.88 close to a $10.25 open. The stock was recently trading near $10.07.
• Analyst sentiment is broadly positive but mixed: Lumexa has an average “Buy” rating and a consensus price target of $17.50, supported by target increases from Barclays and Deutsche Bank, though Weiss Ratings maintained a sell rating and Wall Street Zen downgraded the stock to hold.
• Recent results exceeded expectations: The company reported quarterly EPS of $0.20 versus the $0.03 consensus estimate, revenue of $264.16 million, and fiscal 2026 EPS guidance of $0.71–$0.77.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Get Free Report) gapped up prior to trading on Friday after KeyCorp upgraded the stock to a strong-buy rating. The stock had previously closed at $9.88, but opened at $10.25. Lumexa Imaging shares last traded at $10.0710, with a volume of 11,733 shares changing hands.

A number of other brokerages have also recently issued reports on LMRI. Barclays boosted their target price on shares of Lumexa Imaging from $9.00 to $13.00 and gave the company an "overweight" rating in a research report on Friday, August 28th. Weiss Ratings reiterated a "sell (d)" rating on shares of Lumexa Imaging in a research note on Tuesday. Wall Street Zen lowered shares of Lumexa Imaging from a "buy" rating to a "hold" rating in a research report on Saturday, September 12th. Finally, Deutsche Bank Aktiengesellschaft set a $16.00 target price on shares of Lumexa Imaging in a report on Thursday, August 13th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $17.50.

Institutional Investors Weigh In On Lumexa Imaging

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Squarepoint Ops LLC raised its holdings in shares of Lumexa Imaging by 506.9% during the 2nd quarter. Squarepoint Ops LLC now owns 79,934 shares of the company's stock worth $902,000 after buying an additional 66,763 shares in the last quarter. Readystate Asset Management LP grew its position in Lumexa Imaging by 11.5% in the second quarter. Readystate Asset Management LP now owns 250,533 shares of the company's stock valued at $2,826,000 after acquiring an additional 25,778 shares during the last quarter. AXQ Capital LP acquired a new position in Lumexa Imaging during the second quarter worth about $128,000. Bank of America Corp DE bought a new position in shares of Lumexa Imaging in the second quarter worth about $200,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Lumexa Imaging in the 2nd quarter valued at approximately $24,269,000.

Lumexa Imaging Stock Up 0.7%

The company has a market capitalization of $955.61 million and a P/E ratio of -20.30. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.44 and a current ratio of 1.44. The firm's fifty day moving average is $11.39 and its 200-day moving average is $10.42.

Lumexa Imaging (NASDAQ:LMRI - Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.17. The company had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. As a group, equities research analysts predict that Lumexa Imaging Holdings, Inc. will post 0.25 EPS for the current year.

About Lumexa Imaging

Lumexa Imaging, Inc NASDAQ: LMRI is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company's imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc and adopted the Lumexa Imaging name as part of its corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.